Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
97,918,497
-
Share change
-
+1,732,108
-
Total reported value
-
$2,372,862,063
-
Put/Call ratio
-
55%
-
Price per share
-
$24.25
-
Number of holders
-
364
-
Value change
-
+$45,703,211
-
Number of buys
-
194
-
Number of sells
-
153
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q1 2025
As of 31 Mar 2025,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
364 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,918,497 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, STATE STREET CORP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, DIMENSIONAL FUND ADVISORS LP, and Fundsmith LLP.
This page lists
365
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.